The authors have developed a novel multiplex detection system that quantitatively measures the expression level of 11 messenger RNAs (mRNAs) directly from cell lysates or tissue homogenates without RNA purification. The system incorporates branched DNA (bDNA) technology from Bayer and a multiplex bead array platform from Luminex. In this study, a 21-nt synthetic small interfering RNA (siRNA; specifically designed to knockdown interleukin-8 [IL-8] expression) was delivered into HeLa cells. Using the multiplex bDNA assay, gene expression levels were measured simultaneously from cell lysates for 11 genes. After treating the HeLa cells for 20 h with phorbol myristate acetate (PMA), IL-8 mRNA levels were induced by almost 50-fold; transfection with 30 nM IL-8-specific siRNA reduced the PMA-induced IL-8 mRNA by 80%. In addition, PMA induced mRNA expression in IL-1α (3-fold) and IL-6 (4-fold); however, the IL-8 siRNA did not affect the expression of either of these 2 cytokine genes, indicating that the siRNA was selective for IL-8 mRNA expression. Three housekeeping genes' expression levels were measured under all conditions tested. The multiplex bDNA assay provides a powerful tool for quantitative multiplex gene expression analysis directly from cell lysates, which could be extremely valuable for conservation of rare or difficult-to-obtain samples. (Journal of Biomolecular Screening 2005:549-556) 
INTRODUCTION

R
NA INTERFERENCE is an evolutionarily conserved process whereby a small interfering RNA (siRNA) inhibits the expression of a specific gene. siRNA has been proven to be an effective and powerful tool for studying gene function in numerous organisms and is widely used in mammalian cell phenotypic assays for target validation. 1, 2 Both human epithelial and endothelial cells are known to respond to proinflammatory stimuli tumor necrosis factor alpha (TNFα), phorbol myristate acetate (PMA), and bacterial lipopolysaccharide (LPS), inducing the expression of cytokines such as interleukin-6 (IL-6), 3 interleukin-8 (IL-8), 4 monocyte chemoattractant protein, 5, 6 and granulocyte-macrophage colonystimulating factor (CSF). 7 HeLa cells, although cancerous, are of human epithelial origin and are induced into a proinflammatory response when treated with LPS or PMA. Furthermore, HeLa cells are amenable to transfection, making them ideal for investigating siRNA knockdown of induced gene expression.
It is critical to choose the right control gene to normalize other genes' expression levels when studying a specific siRNA gene knockdown. The messenger RNA (mRNA)-encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH), β-actin, and cyclophilin are ubiquitously expressed as "housekeeping genes" in hundreds to thousands of copies per cell and are frequently used as endogenous controls for quantitative gene expression analysis. 2 However, there is evidence that GAPDH concentration can vary significantly as a function of the conditions to which the cell is exposed; hence, GAPDH is not always an ideal control gene. 1, 2 Thus, multiple housekeeping genes must be screened to find one with the least variation of expression during the siRNA delivery and knockdown process.
In this study, we employed a siRNA to knockdown the IL-8 expression in HeLa cells induced by PMA. In the gene expression analysis, we measured not only the expression level of the target gene IL-8 but also those of other cytokines (IL-1β, IL-6, IL-10, TNFα, interferon [IFN] γ, and CSF2) induced by PMA in the pres-ence and absence of a specific IL-8 siRNA, including 3 housekeeping genes (GAPDH, β-actin, cyclophilin) and a negative control, the bacterial gene diaminopimelate (dapB). We selected a housekeeping gene with the least variance of expression throughout the study to normalize all other genes, including the knockdown target gene IL-8 in the presence and absence of its siRNA.
The ability to quantitatively measure mRNA levels of genes is central to studying gene function. Currently, the expression levels of particular mRNAs present in different biological samples can be measured by a variety of techniques: quantitative PCR (qPCR; TaqMan), Northern blots, RNAase protection analysis, serial analysis of gene expression, and microarrays. These technologies are time-consuming, cumbersome, and/or limited in quantitation. In addition, all of these technologies require purified RNA and/or 2 enzymatic reactions (reverse transcription, PCR amplification) prior to analysis, which may lead to variation in quantitation and the requirement of performing numerous replicates to obtain accurate data. Furthermore, the exponential nature of PCR amplification, together with the small quantities of target molecules, means that trivial variations in reaction components and thermal cycling conditions and mispriming events during the early stages of the PCR can greatly influence the final yield of the amplified product. Finally, qPCR using TaqMan probes is limited in the number of genes that can be analyzed in a multiplexed expression assay by the maximum number of 7 dyes to date, and the cost increases substantially when 4 or more dyes are used. 8, 9 The QuantiGene Reagent System (Genospectra, Fremont, CA) is an accurate, precise, and robust single-plex (1 gene measured/ well) reagent system that is based on the branched DNA (bDNA) technology from Bayer. 10, 11 bDNA amplifies the readout signal rather than the target mRNA, 12, 13 without the requirement for RNA purification, which simplifies the workflow and increases the accuracy of the assay. 12, 14 Recently, the QuantiGene Reagent System has been adapted to the Luminex multiplex bead array platform to enable the measurement of multiple genes per well while still leveraging the attributes of the bDNA technology, that is, a high level of accuracy and no requirement for purified RNA. By conjugating coded capture oligonucleotides to different colored Luminex beads and using bDNA for signal amplification, we have developed a multiplex bDNA assay to analyze the gene expression levels in a multiplex format. In this study, the expression levels of 7 cytokines, 3 housekeeping genes, and 1 bacterial gene were measured simultaneously in an 11-plex format (using the multiplex bDNA assay) and compared to a single-plex QuantiGene assay from the same cell lysates. The gold standard real-time PCR (RT-PCR) was used as non-bDNA-based assays for comparison.
MATERIALS AND METHODS
siRNA preparation
siRNAs (21 nt) for the IL-8 gene were chemically synthesized using phophoramidites (TriLink BioTechnologies, San Diego, CA). The antisense of the IL-8 siRNA was 5′-GAUGGUUCCUUCCGGUGGUdTdT-3′. The synthetic oligoribonucleotides were purified by 15% polyacrylamide gel electrophoresis (PAGE) and were annealed at 500 µM in 950 µL of siRNA annealing buffer (50nM Tris-Cl, 100 nM NaCl, 1 mM EDTA, and 50 U/mL Rnase inhibitor; Genospectra, Fremont, CA). Successful annealing was confirmed by nondenaturing (15%) PAGE.
Cell culture, transfections, and PMA induction
HeLa cells (ATCC, Manassas, VA) were cultured in complete Dulbecco's modified Eagle's medium (DMEM; Invitrogen, Carlsbad, CA) containing 10% serum. The human cell line was regularly passaged at subconfluence and plated 1 day before transfection at 5000 cells per well in a 96-well plate. Cells were transfected at about 80% confluency with 30, 15, 7.5, and 3 nM of the siRNA in siRNA dilution buffer (50 nM Tris-Cl, 100 nM NaCl, 1 mM EDTA, and 0.1% NaN 3 ; Genospectra, Fremont, CA) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). A negative control siRNA was purchased from Ambion (Austin, TX). The stocks of target siRNA and mock siRNA were diluted to 5 µM with Tris-EDTA buffer (TE), The complex was added to appropriate wells (150 µL/well) and incubated at 37°C with 5% CO 2 . Complexes were replaced with DMEM with 5 mM glucose and 10% fetal calf serum (150 µL/ well; Invitrogen, Carlsbad, CA) 4 h after initiation of transfection, and PMA (CalBiochem, San Diego, CA) was added to the cells at a final concentration of 100 nM. After 20 h of induction at 37°C with 5% CO 2 , cells were lysed with QuantiGene cell lysis mixture (Genospectra, Fremont, CA). The cell lysate (75 µL/well) was incubated at 37°C for 30 min and immediately analyzed or stored at -80°C for future use. Cell lysates (50 µL/well) were tested using both the QuantiGene Plex bead-based assay in an 11-plex format and the QuantiGene single-assay format for the target gene IL-8, the other cytokines, and the selected housekeeping gene cyclophilin. The 11 genes in the multiplex assay included 7 cytokines (IL-1β, IL-6, IL-8, IL-10, TNFα, IFNγ, and CSF2), 3 housekeeping genes (GAPDH, β-actin, and cyclophilin), and 1 bacterial gene (dapB). Adenosine triphosphate (ATP) concentrations were measured using the CellTiter-Glo assay kit (Promega, Madison, WI).
RNA quantitation
For the single-plex assay, the standard QuantiGene kit (Genospectra, Fremont, CA) protocol was followed. Briefly, the cell lysate was transferred to a capture well in the presence of the IL-8 or cyclophilin gene-specific probe set and then hybridized at 53°C overnight. Wells were washed twice with bDNA wash buffer and then incubated at 46°C sequentially with an amplifier and an alkaline phosphatase-linked label probe with a wash step between the incubations. After the final wash step, the chemiluminescent alkaline phosphatase substrate dioxitane was added and incubated at 46°C for 30 min. The luminescence signal was detected using an Lmax luminometer (Molecular Devices, Sunnyvale, CA).
In the multiplex bDNA assay, 11 different classes of capture beads were used, with each class of bead conjugated with a unique capture probe oligonucleotide that conferred gene specificity to the bead ( Fig. 1 , Table 1 ). The multiplex bDNA assay is accomplished through the use of fluorescent microspheres (beads) (Luminex, Austin, TX) that act as a unique solid support for the hybridization of specially designed oligonucleotide probe sets. Each probe set contains capture extenders (CEs; usually has 5 CEs), label extenders (LEs; usually has 10 LEs), and blockers (BLs; usually has 6 BLs), whose sequences are selected based on the sequence of the target gene to recognize the particular gene. However, the tails of multiplex CEs discriminate between different fluorescent microspheres within the bead array while quantitatively capturing the associated target mRNA (Fig. 1, Table 1 ). The CE oligos are approximately 40 nucleotides in length. Roughly half of the CEs' sequence is complementary to sections of the target mRNA, and the other half is complementary to the capture oligos that are immobilized onto the beads. The LE oligos are also approximately 40 nucleotides in length. Again, roughly half of the LEs' sequence is complementary to sections of the target mRNA, and the other half is complementary to the branched DNA amplifiers. The blocking probes are used to hybridize across any regions of the target mRNA sequence that are not covered by CEs and LEs. Signal amplification in the multiplex bDNA assay occurs when a branched DNA molecule hybridizes to the LE oligonucleotides. These bDNA molecules contain hybridization sites for 45 biotinylated label probes, which are oligonucleotides hybridized to amplifier molecule branched DNA. Upon addition of streptavidinconjugated phycoerythrin, a 45-fold amplification of fluorescence signal is achieved for each amplifier molecule associated with the target mRNA attached on the bead. Signals (mean fluorescence intensity [MFI]) generated from each bead are proportional to the amount of each mRNA captured on the surface of each genespecific probe set (Fig. 1) . In this fashion, like the QuantiGene single-plex assay, the multiplex bDNA assay enables amplification of the readout signal rather than the target. As a result, a readout signal that is directly proportional to the quantity of target mRNA is achieved without the need of purification and amplification of the target mRNA.
The HeLa cell lysate (50 µL/well) was mixed with the bead array in the presence of probe sets for the 11 genes water; Genospectra, Fremont, CA). The mixture was then pipetted into a 96-well heat-sealed polypropylene plate (ABGene, Rochester, NY) and incubated in a Vortemp 56 shaking incubator (Labnet International, Edison, NJ) for 16 h at 53°C and 600 rpm. The bead array hybridization mixture was transferred to a 96-well filter plate (Millipore, Billerica, MA) and washed using 1X bDNA wash buffer (10% [w/v] lithium lauryl sulfate solution in nuclease-free water; Genospectra, Fremont, CA), followed by serial hybridizations and washing of bDNA amplifier (1 h at 46°C), biotinylated label probe (1 h at 46°C), and streptavidin conjugated phycoerythrin (30 min, room temperature). For the reverse transcription and qPCR, 10 6 vehicle or PMA/ LPS-treated U937 cells were suspended in 1 mL of RLT buffer in RNAeasy Kit (Qiagen, Valencia, CA) for total RNA isolation following the manufacturer's protocol. RNA was quantified with a SpectraMax-384 plus (Molecular Devices, Sunnyvale, CA). Firststrand cDNA was prepared using StrataScript (Stratagene, La Jolla, CA) and amplified in Stratagene's Mx4000 PCR system. qPCR reactions were carried out using TaqMan probes and TaqMan ® Universal PCR Master Mix (Applied Biosystems, Foster City, CA). Each cDNA sample was run in duplicate from 3 RT reactions. StrataScript ® First Strand cDNA Synthesis Kit was used (Stratagene, La Jolla, CA). TaqMan probes for human TNFα was Hs00174128 and for human GAPDH was Hs99999905. Each sample was independently assayed in triplicate. The comparative threshold method was used for data analysis. In brief, the amount of induced TNFα, normalized to GAPDH and relative to control 
Data analysis
All results were reported as the mean ± standard error of measurement. Changes in gene expression levels were analyzed using unpaired Student t-test. A 2-tailed probability <0.05 was considered statistically significant.
RESULTS AND DISCUSSION
HeLa cells in control wells (cells not transfected with siRNA) induced for 20 h with 100 nM PMA showed no significant changes in expressions of the cytokines TNFα, IFNγ, IL-10, and CSF2 (P > 0.05), whereas IL-8, IL-6, and IL-1β expression levels increased significantly (P < 0.05; Fig. 2 ). The expression level of IL-8 was the highest with almost 50-fold induction, whereas IL-1β and IL-6 increased approximately 3-and 4-fold, respectively (Fig. 2) . The fluorescence signals of IL-8 obtained with the cells transfected with siRNA of IL-8 in the absence of PMA induction were the same level of IL-8 in the cells without any treatment (no transfection and no PMA induction; MFI = 28 on average), indicating that the endogenous level of IL-8 expression was low and not affected by the transfection in the current condition for HeLa cells. At the highest concentration of the siRNA used in this study (30 nM), the endogenous levels of all the other target genes remained unchanged, suggesting that there was no off-target effects even when IL-8 mRNA levels were low.
The expression levels of the 3 housekeeping genes were quite different (Fig. 2) , with β-actin showing about 12-fold less expression than did cyclophilin and GAPDH. As expected, the negative control gene dapB was not detected, given that it is a bacterial gene not expressed in mammalian cells. The signals showed for dapB in the figure (Fig. 2) may be due to the assay noise, even though it looked higher than the background levels of IL-10, IFNγ, and CSF2 (Fig. 2) . The signals of dapB were possibly generated by a nonspecific binding of its probe set, which can be improved by designing a better probe set for dapB in the future. Of the housekeeping genes, cyclophilin was the most stable, showing almost no change in expression with or without PMA induction. However, both β-actin and GAPDH expression decreased significantly (P < 0.05) after the PMA treatment. The GAPDH results are similar to those previously described after induction of human mammary fibroblasts cells by 12-otetradecanoyl-phorbol-13-acetate. 15 Therefore, GAPDH and β-actin were not good internal control genes to normalize gene expression studies using PMA-stimulated cells.
As can be seen in Figure 3 , PMA-induced IL-8 expression was knocked down 80% by transfection with 30 nM of the IL-8 siRNA. Furthermore, the IL-8 siRNA efficiently knocked down its cognate mRNA expression in a dose-dependent fashion, demonstrating approximately 60% knockdown at a 10-fold lower concentration (3 nM), whereas the expression of 2 other induced cytokine genes, IL-6 and IL-1β, remained constant at all the concentrations of the siRNA used in this study. These results suggest that the IL-8 siRNA is selective (Fig. 3) . Only TNFα showed a slight drop in expression after transfection of the IL-8 siRNA but not significantly (P > 0.05). At 30 nM of the siRNA, about 20% of the IL-8 expression level remained. The high mRNA levels for IL-8 might soak up the 30 nM of IL-8 siRNA, and a higher concentration of the siRNA might need to achieve more knockdown. However, a higher concentration of siRNA may induce off-target effects. 16, 17 Lowering the concentration of a particular siRNA <100 nM will reduce the silencing efficiency. 16, 17 In summary, the 20% residual IL-8 mRNA expression may be due to cells not transfected, a suboptimal IL-8 siRNA design, and/or the initial high level of expression after induction by PMA and LPS. All these considerations underscore the importance of designing the siRNA to obtain optimal silencing efficiency by using minimal siNRA to avoid the off-target effects. 16, 17 Finally, Lipofectamine 2000 alone and the negative control (using a mock siRNA) did not reduce the expression level of any gene in this study (data not shown). Again, the β-actin and GAPDH expression levels were decreased (P < 0.05) but at the same levels of the PMA treatments without siRNA transfection (Figs. 2 and 3) . The changes of the expression levels of the rest of the genes, including IFNγ, IL-1β, IL-6, IL-10, CSF2, and the housekeeping gene cyclophilin, were insignificant (P > 0.05). The reduction of the 2 housekeeping genes (GAPDH and β-actin) may be due to the were treated with 100 nM PMA for 20 h before lysis. Error bars represent 95% and 99% confidence intervals. *P < 0.05 and **P < 0.01 different from untreated control. MFI, mean fluorescence intensity; TNFα, tumor necrosis factor alpha; IL, interleukin; IFN, interferon; CSF, colony-stimulating factor; dap, diaminopimelate; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
effect of cell cycles caused by PMA treatments. 15 These results further proved that cyclophilin was the best choice for a housekeeping gene in this study.
Recently, the nonspecific induction and repression of mammalian gene expression by siRNAs have become a much-discussed topic. 16 There are at least 2 ways by which transfected siRNAs are proposed to cause nonspecific effects: 1) the length of siRNAs (>30 bp) and 2) the concentration of siRNAs (>100 nM) used during transfection. 16 Long double-stranded RNA (dsRNA) can trigger the cellular dsRNA-dependent protein kinase response. Short siRNAs, particularly single-stranded 21-mers, 16, 17 do not induce this response. Persengiv and colleagues found that nonspecific effects occurred at siRNA concentrations of 100 nM or more but not at concentrations about 20 nM. 16 In the current study, the IL-8 siRNA was 21 bp, and the highest concentration employed was 30 nM; thus, nonspecific induction and repression were not expected.
After titration of the amount of Lipofectamine 2000 used for delivery, we found that the optimal ratio for the complex formation was approximately 10-fold higher than recommended by the vendor. Importantly, we found that this ratio was not harmful to HeLa cells; cell morphology and ATP levels were normal when compared to controls during the transfections (data not shown). Under the new conditions, we were able to reduce siRNA concentration to 30 nM to obtain a good knockdown. On the other hand, we had to use 50 to 100 nM of siRNA for the same knockdown efficiency if we followed the vendor's recommendations, which obviously may cause off-target effects. 16, 17 The same cell lysates were also tested with QuantiGene, a single-plex reagent system (1 gene tested/well). As in the multiplex bDNA assay, the transfections and analysis for the single-plex assay using the QuantiGene kit were performed in 3 independent wells for each treatment. The expression levels of IL-8 and other genes including the housekeeping gene cyclophilin were almost identical to the data obtained from the multiplex assay. The gold standard RT-PCR was employed to compare it with the single-plex bDNA assay (QuantiGene). In this study, the PMA/ LPS-treated U937 cells were lysed and measured directly with the single-plex bDNA assay using the QuantiGene kit (Genospectra, Fremont, CA). From the same treated cells, RNAs were isolated, followed by reverse transcription and RT-PCR reaction. The results showed that the mean fold inductions of TNFα in U937 cells measured by qPCR and single-plex bDNA assay were 323 and 351, respectively. There was no significant difference in the fold induction between the 2 methods (P > 0.05), indicating that the single-plex bDNA assay using the QuantiGene kit was reliable. Although qPCR appeared to be more sensitive, the single-plex bDNA assay was more robust with a much lower coefficient of variation (CV; less than 5%) between repeats and assays. In addition, it was much easier to process the bDNA assay because it did not require RNA purification. The variation (more than 10% CV) generated by qPCR may due to the RNA purification, reverse transcription, and/or amplification. The multiplex bDNA assay leverages 2 powerful technology platforms, the Luminex bead array and bDNA. Both technologies are well established and widely accepted by researchers in both life science and clinical diagnostics. By relying on the specificity and selectivity of nucleic acid hybridization, the multiplex bDNA assay quantitatively measures in parallel the expression of 11 different target mRNAs from cell lysates and tissue homogenates without the need for RNA purification and target amplification. Like QuantiGene, this multiplex assay is highly specific because of the unique design of the probe sets for each mRNA. 10, 11, 13 The assay has a high precision, with intra-CVs of less than 10% and interCVs typically less than 15%. One attractive feature of this technology is the inclusion of in vitro transcribed mRNA templates at known concentrations for each of the target genes, which can be used to generate a standard curve like in a traditional immunoassay (enzyme-linked immunosorbent assay). Based on a threshold of 20% CV to determine the limit detection, we have demonstrated that the multiplex bDNA assay has a sensitivity of 0.04 amol (24,000 RNA transcripts) on average and can detect as low as 6000 copies. Compared with RT-PCR and single bDNA assay, the sensitivity is a weak point for this multiplex technology at this point, and we are currently working to improve it. Based on the current limit detection, one has to use a total of 24,000 cells to adequately measure a 1-copy gene.
The cross-reactivity among the targets in the multiplex assay is negligible (0%-0.04%), and the assay has more than 3 logs of linear dynamic range. Like the single-plex QuantiGene, the multiplex bDNA assay proved to be robust and reproducible. This multiplex technology is a powerful tool for simultaneous measurement of multiple genes in a single sample without RNA purification for direct quantitative analysis of RNAi and gene expression, which is especially valuable for conservation of rare or not easily obtainable samples.
